Durhane Wong-Rieger, President  CEO of the Canadian Organization for Rare Disorders speaks with Alberto Grignolo about patient involvement and engagement, and the future of drug development for rare diseases. Dr. Wong-Rieger is the first DIA Board Member to represent the voice of the patient.

Durhane Wong-Rieger, President CEO of the Canadian Organization for Rare Disorders speaks with Alberto Grignolo about patient involvement and engagement, and the future of drug development for rare diseases. Dr. Wong-Rieger is the first DIA Board Member to represent the voice of the patient.

Patient Engagement and Rare Diseases at DIA

DIA is a global, multidisciplinary, membership association of healthcare professionals that works towards the advancement of lifesaving medicines, therapies, and technologies around the world.

Share Patient Engagement and Rare Diseases at DIA

Sign up to save your podcasts

Patient Engagement and Rare Diseases at DIA

Patient Engagement and Rare Diseases at DIA